Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax

Total 7 results found. Search for [ Nafamostat ]

Results 1 to 7 of 7
PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research

August 4, 2020
FluGuard to be available in market from this week; Sun Pharma to work closely with government and medical community to ensure availability of FluGuard to patients across country

PB Jayakumar
New Delhi, June 9, 2020
Whether India develops a Covid-19 vaccine/drug or not, Indian companies will be preferred partners for global pharma to make and distribute the life-saving drug globally

New Delhi, June 5, 2020
Coronavirus vaccine update: AstraZeneca and Serum Institute of India have signed a licencing agreement to supply 1 billion doses of the Oxford University vaccine to middle and low-income countries, including India

New Delhi, June 5, 2020
COVID-19 drug: The clinical trial will be conducted across 12 centres in India in 210 patients for 10 days and the results of the clinical trial are expected by October

New Delhi, May 30, 2020
Coronavirus vaccine update: Novavax is buying SII's manufacturing plant and planning to produce a billion doses of its coronavirus vaccine by next year

New Delhi, May 29, 2020
Three clinical trials are undergoing to test Nafamostat in Covid-19 patients; these trials are being led by the University of Tokyo Hospital, Japan; Gyeongsang National University Hospital (South Korea); and a collaborative trial by University Hospital, Italy, University of Zurich, Switzerland and Yokohoma City University, Japan